Methotrexate administration for psoriasis
Methotrexate is a systemic treatment used for moderate-to-severe psoriasis that works by suppressing the overactive immune system responsible for the accelerated skin cell growth. It is most commonly prescribed as a once-weekly dose, not daily, to avoid serious toxicity. A healthcare provider will determine the appropriate dose and administration route for each patient, considering their condition's severity, overall health, and tolerance to the medication.
Oral administration: Tablets and liquids
The most common route for methotrexate is oral, typically in tablet form, which is often the first approach for many patients. Oral administration is convenient and doesn't require self-injection. However, it can cause gastrointestinal side effects like nausea or an upset stomach for some individuals.
Standard oral administration schedule:
- Once-weekly dose: The standard approach is to take the entire weekly dose in a single administration.
- Split administration: To minimize nausea and other gastrointestinal side effects, a doctor might prescribe the total weekly dose in two or three smaller portions, taken at intervals over a 24-36 hour period. This can improve tolerability, though patients must be vigilant to not accidentally take their medication daily.
Injectable (parenteral) administration
For patients who experience significant gastrointestinal issues with oral methotrexate or require doses above a certain threshold, a healthcare provider may switch to an injectable form. Subcutaneous (under the skin) injection is the most common parenteral method and offers several benefits.
Benefits of subcutaneous methotrexate:
- Improved bioavailability: Subcutaneous injection allows for more predictable and higher absorption of the medication, especially at certain doses, compared to oral forms.
- Reduced side effects: Since the medication bypasses the digestive tract, it often leads to fewer gastrointestinal side effects, which can improve adherence and patient comfort.
- Faster response: Some studies suggest that subcutaneous administration may result in a faster and more robust clinical response compared to oral therapy.
Procedure for self-injection:
- Prepare your supplies: Gather the prefilled syringe or auto-injector, alcohol pads, and a sharps container. Allow the medication to warm to room temperature for about 30 minutes.
- Choose an injection site: Common sites include the abdomen or thigh. Alternate injection sites each week to prevent irritation. Avoid injecting into areas that are bruised, red, or have active psoriasis plaques.
- Clean the area: Wash your hands thoroughly. Use an alcohol pad to clean the injection site and let it air dry.
- Inject the medication: For a prefilled syringe, pinch a fold of skin and inject at a 90-degree angle. For an auto-injector, place the device firmly against the skin and press the injection button. The device will deliver the dose automatically.
- Remove the needle: Once the injection is complete, withdraw the needle and apply gentle pressure with sterile gauze. Do not rub the site.
- Dispose safely: Place the used syringe or auto-injector into the sharps container. Never recap the needle.
The crucial role of folic acid
Methotrexate is a folate antagonist, and long-term use can deplete the body's folic acid stores, leading to an increase in side effects. To counteract this, doctors prescribe a folic acid supplement to be taken weekly. Taking folic acid does not reduce methotrexate's efficacy for psoriasis but significantly improves tolerability and helps prevent adverse effects like mouth sores, nausea, and liver enzyme abnormalities. It is important to take the folic acid on a different day than the methotrexate dose to ensure the medication's effectiveness is not compromised.
Essential monitoring and safety precautions
Because methotrexate can affect the liver, kidneys, and bone marrow, regular monitoring is mandatory. Your doctor will order blood tests at scheduled intervals to check your blood cell counts, liver function, and kidney function.
Important safety considerations:
- Alcohol consumption: Avoid alcohol entirely while on methotrexate, as the combination can increase the risk of liver damage.
- Pregnancy and conception: Methotrexate is a known teratogen and is contraindicated in pregnancy for both men and women attempting conception. Use effective contraception during treatment. Men should wait at least three months, and women should wait at least one ovulatory cycle (or four months), after stopping methotrexate before attempting to conceive.
- Drug interactions: Inform your doctor about all medications you are taking, including over-the-counter drugs, as some can interfere with methotrexate. Non-steroidal anti-inflammatory drugs (NSAIDs), for example, can increase the risk of methotrexate toxicity.
- Infections and sun sensitivity: Report any signs of infection immediately, as methotrexate can affect your immune system. Your skin may also become more sensitive to sunlight, so protect yourself with sunscreen and clothing.
Oral vs. injectable methotrexate for psoriasis
Feature | Oral Methotrexate | Injectable Methotrexate |
---|---|---|
Administration | Convenient tablets or liquid. | Subcutaneous (under the skin) injections. |
Bioavailability | Can be less reliable, especially at higher doses. | Higher and more predictable absorption into the bloodstream. |
Gastrointestinal Side Effects | More common, including nausea and upset stomach. | Often fewer or less severe GI side effects. |
Efficacy | May be limited by absorption at higher oral quantities. | Can be effective at various administered amounts, leading to a potentially greater response. |
Patient Comfort | May be preferred by those with a fear of needles. | Requires comfort with needles, but can reduce systemic discomfort. |
Adherence | Can be high due to ease of use. Split administration may be confusing. | Can be high due to better tolerability and patient training. |
Conclusion
Properly administering methotrexate is key to managing moderate-to-severe psoriasis effectively. For most patients, oral methotrexate is the initial and most convenient approach. However, for those with gastrointestinal intolerance or a need for doses above a certain limit, injectable (subcutaneous) administration offers improved bioavailability and a more favorable side-effect profile. Whichever route is chosen, adherence to the once-weekly schedule, diligent use of folic acid supplementation, and regular monitoring by a healthcare provider are essential for safety and long-term success. Always consult your healthcare provider to determine the best approach and to stay vigilant for potential side effects. For more information, the National Psoriasis Foundation provides excellent patient resources and detailed treatment information (https://www.psoriasis.org/methotrexate/).